Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 USD | +1.91% | +8.84% | -15.34% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 3.57M | Capitalization | 131M |
---|---|---|---|---|---|
Net income 2024 * | -120M | Net income 2025 * | -121M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 36.8 x |
P/E ratio 2024 * |
-1.08
x | P/E ratio 2025 * |
-1
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.45% |
Latest transcript on Adicet Bio, Inc.
1 day | +1.91% | ||
1 week | +8.84% | ||
Current month | +7.38% | ||
1 month | -20.99% | ||
3 months | -45.58% | ||
6 months | +33.33% | ||
Current year | -15.34% |
Managers | Title | Age | Since |
---|---|---|---|
Aya Jakobovits
FOU | Founder | 71 | 14-10-31 |
Chen Schor
CEO | Chief Executive Officer | 51 | 16-06-30 |
Brian Harvey
DFI | Director of Finance/CFO | 63 | 20-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Dubin
BRD | Director/Board Member | 70 | 20-09-14 |
Carl Gordon
CHM | Chairman | 59 | 15-08-14 |
Michael Kauffman
BRD | Director/Board Member | 60 | 21-11-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 1,487 M€ | +9.17% | - | |
0.00% | 9 M€ | +11.05% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1.6 | +1.91% | 1,057,922 |
24-05-16 | 1.57 | +12.14% | 846,595 |
24-05-15 | 1.4 | +5.26% | 2,665,184 |
24-05-14 | 1.33 | -7.64% | 1,225,598 |
24-05-13 | 1.44 | -2.04% | 877,563 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.34% | 131M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- ACET Stock